- Home
- FBIO vs PYXS Comparison
FBIO vs PYXS Comparison
Compare FBIO & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIO
- PYXS
- Stock Information
- Founded
- FBIO 2006
- PYXS 2018
- Country
- FBIO United States
- PYXS United States
- Employees
- FBIO N/A
- PYXS N/A
- Industry
- FBIO Biotechnology: Pharmaceutical Preparations
- PYXS Biotechnology: Pharmaceutical Preparations
- Sector
- FBIO Health Care
- PYXS Health Care
- Exchange
- FBIO Nasdaq
- PYXS Nasdaq
- Market Cap
- FBIO 88.7M
- PYXS 79.4M
- IPO Year
- FBIO N/A
- PYXS 2021
- Fundamental
- Price
- FBIO $3.38
- PYXS $1.84
- Analyst Decision
- FBIO Strong Buy
- PYXS Strong Buy
- Analyst Count
- FBIO 2
- PYXS 5
- Target Price
- FBIO $16.50
- PYXS $7.75
- AVG Volume (30 Days)
- FBIO 1.1M
- PYXS 731.7K
- Earning Date
- FBIO 08-14-2025
- PYXS 08-14-2025
- Dividend Yield
- FBIO N/A
- PYXS N/A
- EPS Growth
- FBIO N/A
- PYXS N/A
- EPS
- FBIO N/A
- PYXS N/A
- Revenue
- FBIO $59,301,000.00
- PYXS $2,820,000.00
- Revenue This Year
- FBIO $51.59
- PYXS N/A
- Revenue Next Year
- FBIO $44.74
- PYXS N/A
- P/E Ratio
- FBIO N/A
- PYXS N/A
- Revenue Growth
- FBIO N/A
- PYXS N/A
- 52 Week Low
- FBIO $1.33
- PYXS $0.83
- 52 Week High
- FBIO $3.90
- PYXS $5.39
- Technical
- Relative Strength Index (RSI)
- FBIO 71.65
- PYXS 72.24
- Support Level
- FBIO $2.79
- PYXS $1.27
- Resistance Level
- FBIO $3.90
- PYXS $2.00
- Average True Range (ATR)
- FBIO 0.25
- PYXS 0.15
- MACD
- FBIO 0.12
- PYXS 0.07
- Stochastic Oscillator
- FBIO 73.04
- PYXS 80.23
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.